WUXI, China and BETHLEHEM, Pa., March 20, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, today announced that it has selected 4,000...
For more information, please visit
https://www.prnewswire.com/news-releases[...]turing-facility-300617206.html